Glenmark Life Sciences inches up on the BSE
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Glenmark Life Sciences is currently trading at Rs. 632.90, up by 1.70 points or 0.27% from its previous closing of Rs. 631.20 on the BSE.
The scrip opened at Rs. 628.50 and has touched a high and low of Rs. 637.50 and Rs. 627.25 respectively. So far 465 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 675.00 on 16-Oct-2023 and a 52 week low of Rs. 369.00 on 22-Feb-2023.
Last one week high and low of the scrip stood at Rs. 658.90 and Rs. 627.25 respectively. The current market cap of the company is Rs. 7733.92 crore.
The promoters holding in the company stood at 82.85%, while Institutions and Non-Institutions held 5.02% and 12.12% respectively.
The Competition Commission of India (CCI) has given approval for Nirma’s acquisition of majority shareholding in Glenmark Life Sciences. In September this year, Glenmark Pharmaceuticals’ board had approved to divest 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma for Rs 5,651.5 crore.
Ahmedabad-based Nirma is known for its detergents, soap, and dishwashing bars. It is also into the manufacturing of industrial products like soda ash, linear alkyl benzene, alfa olefin sulphonates, fatty acid, glycerine, and sulphuric acid.
Glenmark Life Sciences is in the business of making high-quality drugs by unlocking the possibilities of science.
